You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
Ajanta Pharma USA IncFDAMed source confidence · 83%Jun 30, 2026, 1:02 AM UTC · 8d ago

Ajanta Pharma USA Inc — FDA Class II (D-0594-2026)

Case File

Ajanta Pharma USA Inc is recalling 6,143 bottles of a human prescription product due to a product mix-up. The recall is classified as a Class II recall, indicating a temporary health risk. The affected products are identified by NDC numbers 27241-051 through 27241-056.

Sign in to follow Ajanta Pharma USA Inc and get alerts like this
Key Points
  • Ajanta Pharma USA Inc is recalling 6,143 bottles of a prescription product.
  • The recall is due to a product mix-up with incorrect medication.
  • Affected products are identified by NDC numbers 27241-051 to 27241-056.
  • Consumers should check their medicine cabinets for these products.
  • This type of recall has historically weighed on the stock in the near term.
Why This Matters

Patients who received these products may be at risk of taking the wrong medication. They should check their supplies and return any affected bottles. The recall involves 6,143 bottles.

View original filing →
Sign in to follow Ajanta Pharma USA Inc and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.